EZETIMIBE AND SIMVASTATIN tablet [Actavis Pharma, Inc.]

Immune-regulating drug improves gum disease in mice

Variation in how side effects are reported clouds drug safety

With sales team sidelined by COVID-19, Pfizer braces for a second-quarter revenue hit

Regeneron CEO, R&D chief take 20% pay cuts in year marked by Eylea threats, Sanofi rejig

Merck, with a heavy presence in physician-administered drugs, predicts a $2.1B sales hit from COVID-19

Despite COVID-19 and safety woes, Novartis still eyes blockbuster sales for Beovu

Relieving Parkinson’s disease symptoms with light-based deep brain stimulation

AI could serve as backup to radiologists’ eyes

Covid-19: NHS will restart some paused services this week